Navidea Biopharmaceuticals Inc

ASE:NAVB   9:40:35 AM EDT
-0.02 (-2.30%)
Earnings Announcements

Navidea Biopharmaceuticals Reports Fourth Quarter 2021 Financial Results

Published: 03/23/2022 11:43 GMT
Navidea Biopharmaceuticals Inc (NAVB) - Navidea Biopharmaceuticals Reports Fourth Quarter 2021 Financial Results.
Navidea Biopharmaceuticals Inc - Net Loss Attributable to Common Stockholders for Q4 of 2021 Was $3.7 Million, Or $0.12 per Share.
Navidea Biopharmaceuticals Inc - Navidea Ended Q4 of 2021 With $4.2 Million in Cash and Cash Equivalents.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be $0.00

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.